Volume 144, Issue 5, Pages (May 2013)

Slides:



Advertisements
Similar presentations
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Advertisements

Obesity and the Microbiota
Matrix Metalloproteinase-9 Inhibition Reduces Inflammation and Improves Motility in Murine Models of Postoperative Ileus  Beverley A. Moore, Carl L. Manthey,
Volume 152, Issue 4, Pages e7 (March 2017)
Diet as a Therapy for Irritable Bowel Syndrome: Progress at Last
Volume 149, Issue 1, Pages (July 2015)
Volume 147, Issue 5, Pages e8 (November 2014)
Volume 14, Issue 5, Pages (February 2016)
Volume 12, Issue 3, Pages (September 2012)
Volume 152, Issue 4, Pages (March 2017)
Volume 131, Issue 2, Pages (August 2006)
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Volume 18, Issue 4, Pages (October 2015)
Covering the Cover Gastroenterology
Volume 21, Issue 1, Pages (January 2017)
Volume 140, Issue 5, Pages e6 (May 2011)
Volume 138, Issue 5, Pages e4 (May 2010)
Volume 141, Issue 2, Pages e3 (August 2011)
Gallstone Disease and Cancer Risk: Finding the Bug in the System
Effectiveness of Hepatitis B Treatment in Clinical Practice
Volume 20, Issue 7, Pages (August 2017)
Volume 140, Issue 6, Pages (May 2011)
Outcomes Among Living Liver Donors
Volume 18, Issue 7, Pages (February 2017)
Covering the Cover Gastroenterology
The Gastroenterology Fellowship Match—The First Two Years
Volume 155, Issue 4, Pages (October 2018)
Clinical Challenges and Images in GI
Volume 139, Issue 6, Pages e1 (December 2010)
Eamonn M.M. Quigley  Clinical Gastroenterology and Hepatology 
Volume 155, Issue 2, Pages (August 2018)
Volume 150, Issue 4, Pages (April 2016)
Constipation and the Microbiome: Lumen Versus Mucosa!
The Relationship Between Intestinal Microbiota and the Central Nervous System in Normal Gastrointestinal Function and Disease  Stephen M. Collins, Premsyl.
Volume 141, Issue 3, Pages e4 (September 2011)
Matrix Metalloproteinase-9 Inhibition Reduces Inflammation and Improves Motility in Murine Models of Postoperative Ileus  Beverley A. Moore, Carl L. Manthey,
This Month in Gastroenterology
Patterns and Scales in Gastrointestinal Microbial Ecology
Alterations in the Gut Microbiota Associated with HIV-1 Infection
Colon Cancer: An Update and Future Directions
Volume 16, Issue 6, Pages (December 2014)
Volume 23, Issue 6, Pages (June 2016)
Microbes in Gastrointestinal Health and Disease
Carbon Monoxide, Hydrogen Sulfide, and Nitric Oxide as Signaling Molecules in the Gastrointestinal Tract  Gianrico Farrugia, Joseph H. Szurszewski  Gastroenterology 
This Month in Gastroenterology
Volume 10, Issue 11, Pages (March 2015)
Peripheral and Central P2X3 Receptor Contributions to Colon Mechanosensitivity and Hypersensitivity in the Mouse  Masamichi Shinoda, Bin Feng, G.F. Gebhart 
Starving our Microbial Self: The Deleterious Consequences of a Diet Deficient in Microbiota-Accessible Carbohydrates  Erica D. Sonnenburg, Justin L. Sonnenburg 
Volume 132, Issue 2, Pages (February 2007)
Volume 149, Issue 1, Pages (July 2015)
Volume 153, Issue 4, Pages (October 2017)
Obesity and the Microbiota
Targeting Enteric Neuroplasticity: Diet and Bugs as New Key Factors
Volume 20, Issue 6, Pages (December 2016)
Volume 149, Issue 6, Pages (November 2015)
Abnormalities of Prostaglandins and Cyclooxygenase Enzymes in Female Patients With Slow-Transit Constipation  Ping Cong, Victor Pricolo, Piero Biancani,
Covering the Cover Gastroenterology
The Dawning of a New Editorial Board for Gastroenterology
Epidemiology, Mechanisms, and Management of Diabetic Gastroparesis
Richard J. Saad, William D. Chey  Gastroenterology 
Covering the Cover Gastroenterology
Volume 26, Issue 13, Pages e6 (March 2019)
Microbial communities of the differently treated mice with lupus cluster separately after treatment. Microbial communities of the differently treated mice.
Volume 138, Issue 6, Pages (May 2010)
Electronic Clinical Challenges and Images in GI
by Peter J. Turnbaugh, Vanessa K. Ridaura, Jeremiah J
Volume 18, Issue 7, Pages (February 2017)
Volume 16, Issue 6, Pages (December 2014)
Treating Inflammatory Bowel Disease With Diet: A Taste Test
Volume 25, Issue 6, Pages e5 (June 2019)
Presentation transcript:

Volume 144, Issue 5, Pages 967-977 (May 2013) Complex Interactions Among Diet, Gastrointestinal Transit, and Gut Microbiota in Humanized Mice  Purna C. Kashyap, Angela Marcobal, Luke K. Ursell, Muriel Larauche, Henri Duboc, Kristen A. Earle, Erica D. Sonnenburg, Jessica A. Ferreyra, Steven K. Higginbottom, Mulugeta Million, Yvette Tache, Pankaj J. Pasricha, Rob Knight, Gianrico Farrugia, Justin L. Sonnenburg  Gastroenterology  Volume 144, Issue 5, Pages 967-977 (May 2013) DOI: 10.1053/j.gastro.2013.01.047 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 Humanization of GF mice alters GI transit time. (A) Whole gut transit time measured by the carmine red dye method in GF, humanized, conventional, or conventionalized mice. (B) Distal colonic intraluminal pressure changes recorded using a pressure transducer catheter in conscious GF mice or mice that were humanized 3 days (D3 Post-humanization) or 1 month (Humanized) before measurement. Data are representative of 3 groups of mice for each condition and smoothed with a 2-second time constant to remove breathing artifact and abdominal contractions. (C) Motility index for distal colonic contractility in humanized mice (age matched with GF mice and humanized for 1 month) and ex-GF mice 3 days after humanization as compared with GF mice. Data represent the phasic component of area under the respective curves (pAUC). (D) Mean pAUC for the first 20 minutes (stress period) versus the subsequent 40 minutes and the entire 60 minutes of recording. ANOVA, *P < .05. NS, not significant. Gastroenterology 2013 144, 967-977DOI: (10.1053/j.gastro.2013.01.047) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Alterations in GI transit time influence the microbial composition of the distal gut. (A) Whole gut transit time measured by the carmine dye method in humanized mice before, during, and 7 or 14 days after treatment with PEG or loperamide. (B) Unweighted UniFrac-based PCoA plot (2-dimensional representation of 3-dimensional plot) of gut microbial communities in humanized mice shows that pretreatment samples cluster together and posttreatment samples cluster based on treatment with PEG or loperamide. (C and E) Significant family-level differences in gut microbial communities of humanized mice treated with (C) PEG or (E) loperamide compared with pretreatment controls. (D and F) Unweighted UniFrac-based PCoA plots (2-dimensional representation of 3-dimensional plots with x-axis fixed as time) of gut microbial communities in humanized mice before, during, and 7 or 14 days after treatment with (D) PEG or (F) loperamide show change in microbial community structure upon treatment, which are reversible after discontinuation of treatment. *P < .05. NS, not significant. Gastroenterology 2013 144, 967-977DOI: (10.1053/j.gastro.2013.01.047) Copyright © 2013 AGA Institute Terms and Conditions

Figure 3 Alterations in carbohydrate content of diet alter GI transit time. (A) Whole gut transit time in GF or humanized mice fed (A) a cellulose-enriched diet, (B) a PSD diet, or (C) an FOS-enriched diet compared with standard diet controls. *P < .05. Gastroenterology 2013 144, 967-977DOI: (10.1053/j.gastro.2013.01.047) Copyright © 2013 AGA Institute Terms and Conditions

Figure 4 Polysaccharide content of diet affects distal gut microbial composition. (A, B, and D) Unweighted UniFrac-based PCoA plot (2-dimensional representation of 3-dimensional plot) of gut microbial communities in humanized mice before and during administration of (A) a cellulose-enriched diet, (B) a PSD diet, or (D) FOS-enriched diet shows that samples cluster based on diet. (C) Significant family-level differences in gut microbial communities of humanized mice fed a cellulose-enriched diet compared with standard diet (Pre-cellulose). Gastroenterology 2013 144, 967-977DOI: (10.1053/j.gastro.2013.01.047) Copyright © 2013 AGA Institute Terms and Conditions

Figure 5 Effect of diet on distal gut microbial composition may be mediated in part by changes in GI transit time. Unweighted UniFrac-based PCoA plot of gut microbial communities from humanized mice before (Standard), during (PEG), and 7 (post-PEG D7) or 14 (post-PEG D14) days after treatment with PEG compared with mice fed a cellulose-enriched diet shows clustering of microbial communities with accelerated transit (cellulose, PEG, and Post-PEG D7). Gastroenterology 2013 144, 967-977DOI: (10.1053/j.gastro.2013.01.047) Copyright © 2013 AGA Institute Terms and Conditions

Figure 6 Diet induces changes in microbiota function. (A) Short-chain fatty acid levels in the feces of mice fed FOS-enriched diet compared with a standard diet. No succinate was detected in either condition. (B) Volcano plot showing metabolites that are significantly higher (>100-fold change and P < .01) in feces of mice fed a standard diet (blue) or FOS-enriched diet (red). (C) Increase in normalized concentration of a metabolite with a mass corresponding to 5-HIAA, 191.07. *P < .05. Gastroenterology 2013 144, 967-977DOI: (10.1053/j.gastro.2013.01.047) Copyright © 2013 AGA Institute Terms and Conditions

Appendix Model for interactions between diet, gut microbiota, and GI transit time. (A) GI motility and gut microbiota are closely interrelated and can significantly affect one another. (B) Diet-induced changes in GI transit may partially mediate the effect of diet on microbial composition. (C) Diet-induced changes in microbiota composition and function may alter GI transit time. (D) Together, these factors result in a complex interplay between diet, the gut microbiota, and GI transit. Gastroenterology 2013 144, 967-977DOI: (10.1053/j.gastro.2013.01.047) Copyright © 2013 AGA Institute Terms and Conditions